AAAAAA

   
Results: 1-25 | 26-33
Results: 1-25/33

Authors: GARBARG M LANNFELT L BLOMBERG M WAHLUND LO FREEDMAN SB SCHWARTZ C
Citation: M. Garbarg et al., BIOCHEMICAL MARKERS OF HISTAMINERGIC NEURONS IN CEREBROSPINAL-FLUID OF ALZHEIMER PATIENTS AND IN AN ANIMAL-MODEL OF ALZHEIMERS-DISEASE, Naunyn-Schmiedeberg's archives of pharmacology, 358(1), 1998, pp. 911-911

Authors: KRAUSE M LIGNEAU X STARK H GARBARG M SCHWARTZ JC SCHUNACK W
Citation: M. Krause et al., 4-ALKYNYLPHENYL IMIDAZOLYLPROPYL ETHERS AS SELECTIVE HISTAMINE H-3-RECEPTOR ANTAGONISTS WITH HIGH ORAL CENTRAL-NERVOUS-SYSTEM ACTIVITY, Journal of medicinal chemistry, 41(21), 1998, pp. 4171-4176

Authors: DIMITRIADOU V ROULEAU A TUONG MDT NEWLANDS GJF MILLER HRP LUFFAU G SCHWARTZ JC GARBARG M
Citation: V. Dimitriadou et al., FUNCTIONAL-RELATIONSHIPS BETWEEN SENSORY NERVE-FIBERS AND MAST-CELLS OF DURA-MATER IN NORMAL AND INFLAMMATORY CONDITIONS, Neuroscience, 77(3), 1997, pp. 829-839

Authors: ROULEAU A DIMITRIADOU V TUONG MDT NEWLANDS GFJ MILLER HRP SCHWARTZ JC GARBARG M
Citation: A. Rouleau et al., MAST-CELL SPECIFIC PROTEASES IN RAT-BRAIN - CHANGES IN RATS WITH EXPERIMENTAL ALLERGIC ENCEPHALOMYELITIS, Journal of neural transmission, 104(4-5), 1997, pp. 399-417

Authors: ROULEAU A GARBARG M LIGNEAU X MANTION C LAVIE P ADVENIER C LECOMTE JM KRAUSE M STARK H SCHUNACK W SCHWARTZ JC
Citation: A. Rouleau et al., BIOAVAILABILITY, ANTINOCICEPTIVE AND ANTIINFLAMMATORY PROPERTIES OF BP-2-94, A HISTAMINE H-3 RECEPTOR AGONIST PRODRUG, The Journal of pharmacology and experimental therapeutics, 281(3), 1997, pp. 1085-1094

Authors: KRAUSE M ROULEAU A STARK H LUGER P GARBARG M SCHWARTZ JC SCHUNACK W
Citation: M. Krause et al., NEW POTENT AZOMETHINE PRODRUGS OF THE HISTAMINE H-3 RECEPTOR AGONIST (R)-ALPHA-METHYLHISTAMINE CONTAINING A HETEROARYLPHENYL PARTIAL STRUCTURE, Archiv der pharmazie, 329(4), 1996, pp. 209-215

Authors: DIMITRIADOU V ROULEAU A TUONG MDT LIGNEAU X NEWLANDS GFJ MILLER HRP SCHWARTZ JC GARBARG M
Citation: V. Dimitriadou et al., RAT CEREBRAL MAST-CELLS UNDERGO PHENOTYPIC CHANGES DURING DEVELOPMENT, Developmental brain research, 97(1), 1996, pp. 29-41

Authors: BUVRY A GARBARG M DIMITRIADOU V ROULEAU A NEWLANDS GFJ TAVAKOLI R POATY V LOCKHART A SCHWARTZ JC FROSSARD N
Citation: A. Buvry et al., PHENOTYPIC AND QUANTITATIVE CHANGES IN MAST-CELLS AFTER SYNGENEIC UNILATERAL LUNG TRANSPLANTATION IN THE RAT, Clinical science, 91(3), 1996, pp. 319-327

Authors: SOLDANI G GARBARG M INTORRE L BERTINI S ROULEAU A SCHWARTZ JC
Citation: G. Soldani et al., MODULATION OF PENTAGASTRIN-INDUCED HISTAMINE-RELEASE BY HISTAMINE H-3RECEPTORS IN THE DOG, Scandinavian journal of gastroenterology, 31(7), 1996, pp. 631-638

Authors: KRAUSE M ROULEAU A STARK H GARBARG M SCHWARTZ JC SCHUNACK W
Citation: M. Krause et al., STRUCTURE-ACTIVITY-RELATIONSHIPS OF NOVEL AZOMETHINE PRODRUGS OF THE HISTAMINE H-3 RECEPTOR AGONIST (R)-ALPHA-METHYLHISTAMINE - FROM ALKYLARYL TO SUBSTITUTED DIARYL DERIVATIVES, Die Pharmazie, 51(10), 1996, pp. 720-726

Authors: STARK H PURAND K HULS A LIGNEAU X GARBARG M SCHWARTZ JC SCHUNACK W
Citation: H. Stark et al., [I-125] IODOPROXYFAN AND RELATED-COMPOUNDS - A REVERSIBLE RADIOLIGANDAND NOVEL CLASSES OF ANTAGONISTS WITH HIGH-AFFINITY AND SELECTIVITY FOR THE HISTAMINE HS RECEPTOR, Journal of medicinal chemistry, 39(6), 1996, pp. 1220-1226

Authors: STARK H PURAND K LIGNEAU X ROULEAU A ARRANG JM GARBARG M SCHWARTZ JC SCHUNACK W
Citation: H. Stark et al., NOVEL CARBAMATES AS POTENT HISTAMINE H-3 RECEPTOR ANTAGONISTS WITH HIGH IN-VITRO AND ORAL IN-VIVO ACTIVITY, Journal of medicinal chemistry, 39(5), 1996, pp. 1157-1163

Authors: GANELLIN CR FKYERAT A BANGANDERSEN B ATHMANI S TERTIUK W GARBARG M LIGNEAU X SCHWARTZ JC
Citation: Cr. Ganellin et al., A NOVEL SERIES OF (PHENOXYALKYL)IMIDAZOLES AS POTENT H-3 RECEPTOR HISTAMINE-ANTAGONISTS, Journal of medicinal chemistry, 39(19), 1996, pp. 3806-3813

Authors: IMAMURA M SMITH NC GARBARG M LEVI R
Citation: M. Imamura et al., HISTAMINE H-3 RECEPTOR-MEDIATED INHIBITION OF CALCITONIN-GENE-RELATEDPEPTIDE RELEASE FROM CARDIAC C-FIBERS - A REGULATORY NEGATIVE-FEEDBACK LOOP, Circulation research, 78(5), 1996, pp. 863-869

Authors: STARK H LIPP R ARRANG JM GARBARG M LIGNEAU X SCHWARTZ JC SCHUNACK W
Citation: H. Stark et al., NEW POTENT HISTAMINE H-3 RECEPTOR ANTAGONISTS OF THE AMIDE TYPE, European journal of pharmaceutical sciences, 3(2), 1995, pp. 95-104

Authors: SOLDANI G GARBARG M INTORRE L BERTINI S ROULEAU A SCHWARTZ JC
Citation: G. Soldani et al., MODULATION OF PENTAGASTRIN-INDUCED HISTAMINE-RELEASE BY HISTAMINE H-3RECEPTORS IN THE ANESTHETIZED DOG, The FASEB journal, 9(4), 1995, pp. 953-953

Authors: LIPP R STARK H ARRANG JM GARBARG JM GARBARG M SCHWARTZ JC SCHUNACK W
Citation: R. Lipp et al., SYNTHESIS AND HISTAMINE H-3 RECEPTOR AGONIST ACTIVITY OF MONO-SUBSTITUTED AND DIALKYL-SUBSTITUTED HISTAMINE DERIVATIVES, European journal of medicinal chemistry, 30(3), 1995, pp. 219-225

Authors: LESCHKE C ELZ S GARBARG M SCHUNACK W
Citation: C. Leschke et al., SYNTHESIS AND HISTAMINE H-1 RECEPTOR AGONIST ACTIVITY OF A SERIES OF 2-PHENYLHISTAMINES, 2-HETEROARYLHISTAMINES, AND ANALOGS, Journal of medicinal chemistry, 38(8), 1995, pp. 1287-1294

Authors: KRAUSE M ROULEAU A STARK H LUGER P LIPP R GARBARG M SCHWARTZ JC SCHUNACK W
Citation: M. Krause et al., SYNTHESIS, X-RAY CRYSTALLOGRAPHY, AND PHARMACOKINETICS OF NOVEL AZOMETHINE PRODRUGS OF (R)-ALPHA-METHYLHISTAMINE - HIGHLY POTENT AND SELECTIVE HISTAMINE H-3 RECEPTOR AGONISTS, Journal of medicinal chemistry, 38(20), 1995, pp. 4070-4079

Authors: GANELLIN CR HOSSEINI SK KHALAF YS TERTIUK W ARRANG JM GARBARG M LIGNEAU X SCHWARTZ JC
Citation: Cr. Ganellin et al., DESIGN OF POTENT NON-THIOUREA H-3 RECEPTOR HISTAMINE-ANTAGONISTS, Journal of medicinal chemistry, 38(17), 1995, pp. 3342-3350

Authors: DELAUNOIS A GUSTIN P GARBARG M ANSAY M
Citation: A. Delaunois et al., MODULATION OF ACETYLCHOLINE, CAPSAICIN AND SUBSTANCE-P EFFECTS BY HISTAMINE H-3 RECEPTORS IN ISOLATED-PERFUSED RABBIT LUNGS, European journal of pharmacology, 277(2-3), 1995, pp. 243-250

Authors: SMITH NCE IMAMURA M GARBARG M LEVI R
Citation: Nce. Smith et al., HISTAMINE H-3 RECEPTORS DOWN-REGULATE THE RELEASE OF CALCITONIN-GENE-RELATED PEPTIDE FROM CARDIAC C-FIBERS, Circulation, 92(8), 1995, pp. 2714-2714

Authors: GOTHERT M GARBARG M HEY JA SCHLICKER E SCHWARTZ JC LEVI R
Citation: M. Gothert et al., NEW ASPECTS OF THE ROLE OF HISTAMINE IN CARDIOVASCULAR FUNCTION - IDENTIFICATION, CHARACTERIZATION, AND POTENTIAL PATHOPHYSIOLOGICAL IMPORTANCE OF H-3 RECEPTORS, Canadian journal of physiology and pharmacology, 73(5), 1995, pp. 558-564

Authors: STARK H LIPP R ARRANG JM GARBARG M SCHWARTZ JC SCHUNACK W
Citation: H. Stark et al., ACYLATED AND ALKYLATED HISTAMINE DERIVATIVES AS NEW HISTAMINE H-3 RECEPTOR ANTAGONISTS, European journal of medicinal chemistry, 29(9), 1994, pp. 695-700

Authors: DIMITRIADOU V ROULEAU A TUONG MDT NEWLANDS GJF MILLER HRP LUFFAU G SCHWARTZ JC GARBARG M
Citation: V. Dimitriadou et al., FUNCTIONAL-RELATIONSHIP BETWEEN MAST-CELLS AND C-SENSITIVE NERVE-FIBERS EVIDENCED BY HISTAMINE H-3 RECEPTOR MODULATION IN RAT LUNG AND SPLEEN, Clinical science, 87(2), 1994, pp. 151-163
Risultati: 1-25 | 26-33